A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B [PDF]
Michel Vidaud+5 more
openalex +1 more source
ABSTRACT Backgrounds Pulmonary embolism (PE) is a common disease and a common cause of death. However, it is currently unclear which clinically common drugs can lead to PE. Methods We collected, organized, and analyzed reports from the first quarter of 2018 to the fourth quarter of 2022.
Hang Chen+11 more
wiley +1 more source
Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes [PDF]
Allen, G+7 more
core
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review. [PDF]
Prezotti AN+6 more
europepmc +1 more source
Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene [PDF]
H. J. Hassan+8 more
openalex +1 more source
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype. [PDF]
Rodeghiero F+25 more
europepmc +1 more source
Studies of lymph nodes from patients with classical hemophilia [PDF]
W.A. Andes+4 more
openalex +1 more source
Tympanostomy tubes in children with hemophilia a [PDF]
Stephen L. Liston+3 more
openalex +1 more source
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 [PDF]
Curiel, David T+5 more
core +1 more source
An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India. [PDF]
Bhatt P, Patel H.
europepmc +1 more source